Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.34 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.34 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | CFTR | P13569 | 1/20 | 0.31 |
| ▸ | GOPC | Q9HD26 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12404436 | 0.86 | — | — | |
| SCHEMBL23996388 | 0.69 | KMT2A (0.39) | KMT2AATMSLC6A2SLC6A4SLC6A3 | |
| SCHEMBL11932651 | 0.69 | TP53 (0.38) | KMT2AATMSLC6A2SLC6A4SLC6A3 | |
| SCHEMBL24671964 | 0.67 | SLC6A2 (0.39) | KMT2AATMSLC6A2SLC6A4SLC6A3 | |
| SCHEMBL16270678 | 0.67 | SLC6A2 (0.39) | KMT2AATMSLC6A2SLC6A4SLC6A3 | |
| SCHEMBL11932649 | 0.66 | SCN1A (0.39) | KMT2AATMSLC6A2SLC6A4SLC6A3 | |
| SCHEMBL11932650 | 0.66 | HTR2A (0.41) | KMT2AATMSLC6A2SLC6A4SLC6A3 | |
| SCHEMBL12997361 | 0.66 | HMBS (0.33) | KMT2AATMSLC6A2SLC6A4SLC6A3 | |
| SCHEMBL12246830 | 0.65 | KMT2A (0.36) | KMT2AATMSLC6A2SLC6A4SLC6A3 | |
| SCHEMBL14613517 | 0.65 | TAAR1 (0.40) | KMT2AATMSLC6A4SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130079528-A1 | GEOMETRIC SYNTHESIS OF PORPHYRIN RODS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2013-03-28 | — | — | US | disclosed |
| US-7939656-B2 | Geometric synthesis of porphyrin rods | NORTH CAROLINA STATE UNIVERSITY (US) | 2011-05-10 | — | — | US | disclosed |
| US-20100305314-A1 | GEOMETRIC SYNTHESIS OF PORPHYRIN RODS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2010-12-02 | — | — | US | disclosed |
| US-7799910-B2 | Geometric synthesis of porphyrin rods | NORTH CAROLINA STATE UNIVERSITY (US) | 2010-09-21 | — | — | US | disclosed |
| US-20070155963-A1 | Geometric synthesis of porphyrin rods | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2007-07-05 | — | — | US | disclosed |
| US-20070155963-A1 | Geometric synthesis of porphyrin rods | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2007-07-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130079528-A1 | GEOMETRIC SYNTHESIS OF PORPHYRIN RODS | PPOX, DLD, PYCR1 | KMT2A 2866/4885ATM 4810/4885SLC6A2 4260/4885 |
| US-20070155963-A1 | Geometric synthesis of porphyrin rods | PPOX, DLD, PYCR1 | KMT2A 2866/4885ATM 4810/4885SLC6A2 4260/4885 |
| US-20100305314-A1 | GEOMETRIC SYNTHESIS OF PORPHYRIN RODS | PPOX, DLD, PYCR1 | KMT2A 2866/4885ATM 4810/4885SLC6A2 4260/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.